PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic Cancer
Clinical trial NCT04518800 · UNKNOWN
Trial details
- NCT number
- NCT04518800
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-18
- Primary completion
- 2021-08-18
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.